Detalles de la búsqueda
1.
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Lancet
; 394(10212): 1915-1928, 2019 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31679945
2.
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer.
BMC Cancer
; 19(1): 196, 2019 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30832606
3.
Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012.
Cancer Sci
; 109(3): 771-776, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29284202
4.
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.
Lancet Oncol
; 17(7): 956-965, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27247226
5.
Correction to: Resection of Isolated Pelvic Recurrences after Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome.
Ann Surg Oncol
; 28(Suppl 3): 883, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34125352
6.
Correction to: Resection of Isolated Pelvic Recurrences after Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome.
Ann Surg Oncol
; 28(Suppl 3): 865, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33237451
7.
Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens.
FASEB J
; 27(2): 581-9, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23104982
8.
Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha.
Bioconjug Chem
; 23(8): 1704-11, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22812530
9.
Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity.
Bioorg Med Chem Lett
; 22(10): 3412-7, 2012 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22525314
10.
FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.
BMC Cancer
; 11: 245, 2011 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-21668992
11.
Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040.
J Natl Cancer Inst
; 113(2): 171-181, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32407532
12.
Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as Monotherapy.
Clin Cancer Res
; 25(5): 1564-1573, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30442684
13.
Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14).
Int J Radiat Oncol Biol Phys
; 71(5): 1351-5, 2008 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18640496
14.
Clinical implications of fibroblast activation protein in patients with colon cancer.
Clin Cancer Res
; 13(6): 1736-41, 2007 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17363526
15.
Dipeptidyl peptidase 8/9-like activity in human leukocytes.
J Leukoc Biol
; 81(5): 1252-7, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17287297
16.
Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): A systematic literature review.
Oral Oncol
; 84: 108-120, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30115469
17.
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.
Int J Radiat Oncol Biol Phys
; 69(2): 358-63, 2007 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17532577
18.
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study.
J Clin Oncol
; 35(36): 4050-4056, 2017 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28837405
19.
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection.
Am J Clin Oncol
; 40(4): 393-398, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26986978
20.
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.
J Clin Invest
; 127(8): 2930-2940, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28650338